SPIMACO
الدوائيةTechnical Analysis & Signals
The pharmaceutical stock shows sideways movement with mixed signals in the Saudi market.
Technical Analysis
The stock is currently trading at 29.94 SAR, with the Relative Strength Index (RSI) at 44.6 indicating a balance between buying and selling. Additionally, the MACD shows a negative value, which may suggest weakness in upward momentum.
Support & Resistance Levels
The main support level for the stock is at 29.6 SAR, while the resistance level is at 30.1 SAR. The stock may trend towards testing these levels if sideways movement continues.
Volume Analysis
Volume data has not been provided, but trading volume is expected to be influenced by overall market movement. An increase in trading volume may indicate greater investor interest.
Fundamental Factors
The price-to-earnings (P/E) ratio stands at 27.7, which may indicate a high valuation for the stock. Additionally, the dividend yield is 0%, meaning no dividends are currently distributed to shareholders.
Risk Factors
Potential risks include general market volatility and macroeconomic impacts on the pharmaceutical sector. The sideways movement of the stock may indicate uncertainty among investors.
Recommendation
Disclaimer: This analysis is for educational purposes only and does not constitute investment advice. It is advisable to monitor support and resistance levels and make informed decisions based on comprehensive analysis.
Automated analysis is based on historical data and technical indicators and may not reflect future market conditions.
Financial Fundamentals
Price Data
Price Chart - SPIMACO
2070Technical Analysis
Moving Averages
Momentum Indicators
Bollinger Bands
Within BandTrend Strength (ADX)
Moderate TrendFinancial Summary
Valuation
- Market Cap
- 3.57B
- P/E Ratio
- 27.70
- P/B Ratio
- 2.20
- EPS (Earnings/Share)
- 1.08
Profitability
- Revenue
- 1.71B
- Net Income
- 184.36M
- Return on Equity (ROE)
- +10.00%
- Shares Outstanding
- 119.36M
Balance Sheet
- Total Assets
- N/A
- Total Debt
- 1.43B
- Debt/Equity
- 0.81
- Free Float %
- +72.5%
Dividends & Margins
- Dividend Yield
- 0.00%
- Dividend/Share
- 0.00
- Book Value
- 13.61
Financial data extracted from published quarterly reports. All values in SAR unless otherwise stated.
Historical Financial Data
4 years| Year | Revenue | Net Income | Total Assets | Total Debt | EPS |
|---|---|---|---|---|---|
| 2024 | 1.68B +1.6% | 24.54M +148.4% | 4.32B +11.3% | 1.51B +35.1% | 0.21 +148.8% |
| 2023 | 1.66B +16.4% | -50.73M +69.3% | 3.88B +1.3% | 1.12B +3.5% | -0.43 +68.8% |
| 2022 | 1.42B -2.6% | -165.13M -724.2% | 3.83B -13.6% | 1.08B -16.5% | -1.38 -727.3% |
| 2021 | 1.46B | 26.45M | 4.43B | 1.29B | 0.22 |
Historical data sourced from Yahoo Finance and may differ from official audited financial reports.
Price Forecast
These forecasts are based on technical analysis and AI and do not constitute investment advice. Past performance does not guarantee future results.
News & Events
Alawwal Capital sets 11 Saudi top picks in 2026
SPIMACO sets up subsidiary to manufacture biopharma products
SPIMACO expects upbeat performance to continue in Q4 2025
SPIMACO partners with Boston Oncology to locally manufacture 4 products
SPIMACO inks SAR 200M financing deal with SNB
SPIMACO inaugurates oncology, high-potent drug plant
United Securities issues Q4 2025 earnings forecasts
Key events to drive Saudi-listed firms' performance in Q4 2025
News source: Argaam (argaam.com)
Dividend History
Dividend data from Tadawul records. All amounts in SAR. Estimated yield calculated based on year-end price.
Ownership Structure
Data source: Yahoo FinanceLast updated: 2026-05-11
Risk Assessment
Risk Factors
Average True Range 3.2% of stock price
Trading volume below average
P/E ratio 27.7
Debt-to-equity ratio 0.81
ADX indicator at 20
Moderate risk factors with some sector pressures
This assessment is automated based on quantitative data and does not constitute investment advice. Please consult a licensed financial advisor before making investment decisions.
FAQ
1 What is SPIMACO stock price today?
SPIMACO (2070) stock price today is 29.94 SAR, gaining by +0.81% compared to the previous session close. The 52-week price range is between 21.76 SAR and 33.12 SAR.
2 What is SPIMACO stock valuation?
The automated analysis signal for SPIMACO is "Hold" with 65% confidence. The P/E ratio is 27.7. The P/B ratio is 2.20.
3 Is SPIMACO Shariah-compliant?
Yes, SPIMACO (2070) is Shariah-compliant according to the latest lists approved by relevant Shariah authorities.
4 What are SPIMACO dividend distributions?
No dividend payment data is currently available for SPIMACO. The company may not distribute dividends or the data has not been updated yet.
5 What is SPIMACO weekly performance?
SPIMACO performance over different time periods: weekly change -4.10%, monthly +2.18%, and year-to-date +14.45%. The stock is currently trading with a volume of 302,754 shares.
6 What is the target level for SPIMACO?
According to automated analysis for SPIMACO: Medium-term target (1-3 months): 31.26 SAR. Support level: 29.60 SAR. Resistance level: 30.10 SAR. Note: These are automated analytical levels and do not constitute investment advice.
Disclaimer
The information provided on this page is for educational and analytical purposes only and does not constitute investment advice or a recommendation to buy or sell. Past performance does not guarantee future results. All investments involve risk including loss of capital. Please consult a licensed financial advisor before making any investment decisions.
Automated analysis relies on historical data and technical indicators and may not reflect future market conditions.